Transcarent IPO
Transcarent is a healthcare platform that provides personalized healthcare guidance and navigation services to employees and their families. The company combines technology, data analytics, and human support to help users navigate complex healthcare decisions and access high-quality, cost-effective care. Founded by former Livongo CEO Glen Tullman, the company has attracted significant investor interest due to its innovative approach to employee healthcare benefits.
Key Facts
| Industry | Healthcare Technology |
| Founded | 2020 |
| Headquarters | San Francisco, CA |
| Employees | 500-1,000 |
| Website | transcarent.com |
| Funding | Series C at $2.2B valuation. Total raised: ~$298M |
About Transcarent
Transcarent is a health and care experience platform that serves as a comprehensive healthcare solution for employers and their employees. The company provides a unified platform that combines telehealth services, prescription management, specialist care coordination, surgical care, and health plan administration. Transcarent's approach focuses on simplifying the healthcare experience by providing personalized guidance and eliminating the complexity typically associated with navigating health benefits and care options.
Founded by former Livongo CEO Glen Tullman, Transcarent aims to address the fragmentation in employer-sponsored healthcare by offering an integrated platform that handles everything from routine care to complex medical procedures. The company partners directly with employers to provide their workforce with streamlined access to high-quality, cost-effective healthcare services. Transcarent's model emphasizes transparency in pricing and outcomes, while leveraging technology to match members with appropriate care providers and treatment options based on their specific needs and location.
IPO Status
Transcarent has raised substantial funding from investors, including a $200 million Series C round in 2022 that valued the company at $2.2 billion. The company has been growing rapidly and expanding its partnerships with major employers and health plans. While there has been speculation about a potential IPO given the company's growth trajectory and valuation, no official IPO plans have been announced. The company's focus on improving healthcare outcomes while reducing costs has positioned it well in the competitive healthcare technology market. However, like many private companies, Transcarent may be waiting for more favorable market conditions before considering going public.
Competitors
Frequently Asked Questions
Does Transcarent have a stock?
No, Transcarent has not had an IPO and remains a private company. The company has raised significant private funding but has not announced any plans to go public.
When is the Transcarent IPO date?
There is no confirmed IPO date for Transcarent, as the company has not announced any plans to go public. Any timeline for a potential IPO remains speculative.
How can I buy Transcarent stock?
You cannot buy Transcarent stock as it is currently a private company. The stock is not available on public exchanges and is only accessible to qualified private investors.
Stay Updated on the Transcarent IPO
Get real-time alerts when Transcarent files for an IPO, prices shares, or begins trading.
Get IPO Alerts